MoonLake Immunotherapeutics Stock Draws Wall Street Attention Post Monday’s Plunge: Retail Sees Significant Upside
Needham analyst Serge Belanger lowered the firm's price target on the stock to $20 from $66 but kept a ‘Buy’ rating on the shares.
Stocktwits·1d ago
More News
Capricor Stock Rises Pre-Market Over Fresh Hopes Of Deramiocel Approval In Treating Genetic Disorder
The company announced on Thursday that it held a meeting with the agency and plans to submit data from its HOPE-3 clinical trial as part of its current application.
Stocktwits·7d ago
Should iShares Morningstar Small-Cap ETF (ISCB) Be on Your Investing Radar?
Style Box ETF report for ISCB
Zacks·1mo ago
Trump Media & Tech Stock Plummets, Retail Gets ‘Extremely Bearish’ After Key Execs Dump Shares
A six-month lock-up period barring former President Donald Trump from selling his shares in the company is also nearing its end.
Stocktwits·1y ago
Trump Media Stock Declines To Record Post-Merger Low, Retail Sentiment Sours
The stock, closely tied to former President Trump’s actions and legal issues, has plunged over 61% since going public via a SPAC merger this year.